Alexion Drug Patent Portfolio
Alexion owns 1 orange book drug protected by 2 US patents Given below is the list of Alexion's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12076319 | Therapeutic regimens for treatment of paroxysmal nocturnal hemoglobinuria | 02 Aug, 2038 | Active |
| US9796741 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders | 25 Feb, 2035 | Active |
Latest Legal Activities on Alexion's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Alexion.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| transaction for FDA Determination of Regulatory Review Period | 16 Jun, 2025 | US9796741 |
| Information Disclosure Statement (IDS) Filed | 16 Jun, 2025 | US9796741 |
| Patent eCofC Notification | 01 Apr, 2025 | US12076319 |
| Email Notification | 01 Apr, 2025 | US12076319 |
| Recordation of Patent eCertificate of Correction | 01 Apr, 2025 | US12076319 |
| Mail Patent eCofC Notification | 01 Apr, 2025 | US12076319 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 25 Mar, 2025 | US9796741 |
| Mail Certificate of Correction Memo | 17 Mar, 2025 | US12076319 |
| Certificate of Correction Memo | 13 Mar, 2025 | US12076319 |
| Post Issue Communication - Certificate of Correction | 13 Mar, 2025 | US12076319 |
| Second letter to regulating agency to determine regulatory review period | 18 Oct, 2024 | US9796741 |
| Letter from FDA or Dept of Agriculture re PTE application | 09 Oct, 2024 | US9796741 |
| Mail Patent eGrant Notification | 03 Sep, 2024 | US12076319 |
| Email Notification | 03 Sep, 2024 | US12076319 |
| Recordation of Patent Grant Mailed | 03 Sep, 2024 | US12076319 |
Alexion's Family Patents
Alexion Drug List
Given below is the complete list of Alexion's drugs and the patents protecting them.
1. Voydeya
Voydeya is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12076319 | Therapeutic regimens for treatment of paroxysmal nocturnal hemoglobinuria |
02 Aug, 2038
(12 years from now)
| Active |
| US9796741 | Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders |
25 Feb, 2035
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Voydeya's drug page